Long-lasting HIV drug could help people who can’t take daily PrEP pills.
Read More
Here's everything you need to know about lenacapavir, the newly approved HIV-prevention injection
RELATED ARTICLES
ABOUT US
TIC News was born out of a desire to inspire and motivate. Our platform is an extension of "Thinking into Character," a transformative self-development programme created by Dr. Selva Pankaj, CEO of Regent College. Recognising the profound impact that positive news can have on an individual's mindset and overall well-being, we sought to create a space dedicated entirely to uplifting content.
Contact us: [email protected]
FOLLOW US
© TiC News 2025